- call +1-201-465-4211
- email sales@mrinsights.biz
Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.
Scope of the Report:
This report studies the Narcolepsy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Narcolepsy market by product type and applications/end industries.
People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
The global Narcolepsy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Narcolepsy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Jazz Pharmaceuticals
Bioprojet
Arena Pharmaceuticals
Graymark Healthcare
Mylan
Teva Pharmaceutical Industries
Novartis
Shire
Shionogi
Ligand Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Type 1 Narcolepsy
Type 2 Narcolepsy
Market Segment by Applications, can be divided into
Hospitals
Clinics
Retail Pharmacies
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Narcolepsy Market Overview
1.1 Product Overview and Scope of Narcolepsy
1.2 Classification of Narcolepsy by Types
1.2.1 Global Narcolepsy Revenue Comparison by Types (2017-2023)
1.2.2 Global Narcolepsy Revenue Market Share by Types in 2017
1.2.3 Type 1 Narcolepsy
1.2.4 Type 2 Narcolepsy
1.3 Global Narcolepsy Market by Application
1.3.1 Global Narcolepsy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Narcolepsy Market by Regions
1.4.1 Global Narcolepsy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Narcolepsy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Narcolepsy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Narcolepsy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Narcolepsy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Narcolepsy Status and Prospect (2013-2023)
1.5 Global Market Size of Narcolepsy (2013-2023)
2 Manufacturers Profiles
2.1 Jazz Pharmaceuticals
2.1.1 Business Overview
2.1.2 Narcolepsy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Jazz Pharmaceuticals Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bioprojet
2.2.1 Business Overview
2.2.2 Narcolepsy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bioprojet Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Arena Pharmaceuticals
2.3.1 Business Overview
2.3.2 Narcolepsy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Arena Pharmaceuticals Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Graymark Healthcare
2.4.1 Business Overview
2.4.2 Narcolepsy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Graymark Healthcare Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mylan
2.5.1 Business Overview
2.5.2 Narcolepsy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical Industries
2.6.1 Business Overview
2.6.2 Narcolepsy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Pharmaceutical Industries Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Narcolepsy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.8 Shire
2.8.1 Business Overview
2.8.2 Narcolepsy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Shire Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.9 Shionogi
2.9.1 Business Overview
2.9.2 Narcolepsy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Shionogi Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ligand Pharmaceuticals
2.10.1 Business Overview
2.10.2 Narcolepsy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ligand Pharmaceuticals Narcolepsy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Narcolepsy Market Competition, by Players
3.1 Global Narcolepsy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Narcolepsy Players Market Share
3.2.2 Top 10 Narcolepsy Players Market Share
3.3 Market Competition Trend
4 Global Narcolepsy Market Size by Regions
4.1 Global Narcolepsy Revenue and Market Share by Regions
4.2 North America Narcolepsy Revenue and Growth Rate (2013-2018)
4.3 Europe Narcolepsy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Narcolepsy Revenue and Growth Rate (2013-2018)
4.5 South America Narcolepsy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Narcolepsy Revenue and Growth Rate (2013-2018)
5 North America Narcolepsy Revenue by Countries
5.1 North America Narcolepsy Revenue by Countries (2013-2018)
5.2 USA Narcolepsy Revenue and Growth Rate (2013-2018)
5.3 Canada Narcolepsy Revenue and Growth Rate (2013-2018)
5.4 Mexico Narcolepsy Revenue and Growth Rate (2013-2018)
6 Europe Narcolepsy Revenue by Countries
6.1 Europe Narcolepsy Revenue by Countries (2013-2018)
6.2 Germany Narcolepsy Revenue and Growth Rate (2013-2018)
6.3 UK Narcolepsy Revenue and Growth Rate (2013-2018)
6.4 France Narcolepsy Revenue and Growth Rate (2013-2018)
6.5 Russia Narcolepsy Revenue and Growth Rate (2013-2018)
6.6 Italy Narcolepsy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Narcolepsy Revenue by Countries
7.1 Asia-Pacific Narcolepsy Revenue by Countries (2013-2018)
7.2 China Narcolepsy Revenue and Growth Rate (2013-2018)
7.3 Japan Narcolepsy Revenue and Growth Rate (2013-2018)
7.4 Korea Narcolepsy Revenue and Growth Rate (2013-2018)
7.5 India Narcolepsy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Narcolepsy Revenue and Growth Rate (2013-2018)
8 South America Narcolepsy Revenue by Countries
8.1 South America Narcolepsy Revenue by Countries (2013-2018)
8.2 Brazil Narcolepsy Revenue and Growth Rate (2013-2018)
8.3 Argentina Narcolepsy Revenue and Growth Rate (2013-2018)
8.4 Colombia Narcolepsy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Narcolepsy by Countries
9.1 Middle East and Africa Narcolepsy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Narcolepsy Revenue and Growth Rate (2013-2018)
9.3 UAE Narcolepsy Revenue and Growth Rate (2013-2018)
9.4 Egypt Narcolepsy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Narcolepsy Revenue and Growth Rate (2013-2018)
9.6 South Africa Narcolepsy Revenue and Growth Rate (2013-2018)
10 Global Narcolepsy Market Segment by Type
10.1 Global Narcolepsy Revenue and Market Share by Type (2013-2018)
10.2 Global Narcolepsy Market Forecast by Type (2018-2023)
10.3 Type 1 Narcolepsy Revenue Growth Rate (2013-2023)
10.4 Type 2 Narcolepsy Revenue Growth Rate (2013-2023)
11 Global Narcolepsy Market Segment by Application
11.1 Global Narcolepsy Revenue Market Share by Application (2013-2018)
11.2 Narcolepsy Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Retail Pharmacies Revenue Growth (2013-2018)
12 Global Narcolepsy Market Size Forecast (2018-2023)
12.1 Global Narcolepsy Market Size Forecast (2018-2023)
12.2 Global Narcolepsy Market Forecast by Regions (2018-2023)
12.3 North America Narcolepsy Revenue Market Forecast (2018-2023)
12.4 Europe Narcolepsy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Narcolepsy Revenue Market Forecast (2018-2023)
12.6 South America Narcolepsy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Narcolepsy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Narcolepsy Picture
Table Product Specifications of Narcolepsy
Table Global Narcolepsy and Revenue (Million USD) Market Split by Product Type
Figure Glob
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
